Alaunos Therapeutics, Inc. (TCRT)
Total Valuation
TCRT has a market cap or net worth of $30.32 million. The enterprise value is $19.55 million.
Market Cap | 30.32M |
Enterprise Value | 19.55M |
Important Dates
The next estimated earnings date is Wednesday, May 8, 2024, before market open.
Earnings Date | May 8, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
TCRT has 16.04 million shares outstanding. The number of shares has increased by 11.60% in one year.
Shares Outstanding | 16.04M |
Shares Change (YoY) | +11.60% |
Shares Change (QoQ) | +0.10% |
Owned by Insiders (%) | 4.40% |
Owned by Institutions (%) | 17.13% |
Float | 13.34M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 2,021.27 |
Forward PS | n/a |
PB Ratio | 2.18 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 1,303.07 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.75, with a Debt / Equity ratio of 0.08.
Current Ratio | 2.75 |
Quick Ratio | n/a |
Debt / Equity | 0.08 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -11.98 |
Financial Efficiency
Return on equity (ROE) is -140.70% and return on invested capital (ROIC) is -232.79%.
Return on Equity (ROE) | -140.70% |
Return on Assets (ROA) | -90.60% |
Return on Capital (ROIC) | -232.79% |
Revenue Per Employee | $441 |
Profits Per Employee | -$1.07M |
Employee Count | 34 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -77.45% in the last 52 weeks. The beta is -0.30, so TCRT's price volatility has been lower than the market average.
Beta (1Y) | -0.30 |
52-Week Price Change | -77.45% |
50-Day Moving Average | 2.01 |
200-Day Moving Average | 2.83 |
Relative Strength Index (RSI) | 49.37 |
Average Volume (30 Days) | 244,474 |
Short Selling Information
The latest short interest is 1.55 million, so 9.66% of the outstanding shares have been sold short.
Short Interest | 1.55M |
Short Previous Month | 1.65M |
Short % of Shares Out | 9.66% |
Short % of Float | 11.62% |
Short Ratio (days to cover) | 10.99 |
Income Statement
In the last 12 months, TCRT had revenue of $15,000 and -$36.46 million in losses. Loss per share was -$2.40.
Revenue | 15,000 |
Gross Profit | 15,000 |
Operating Income | -35.08M |
Pretax Income | -36.46M |
Net Income | -36.46M |
EBITDA | -29.44M |
EBIT | -33.65M |
Loss Per Share | -$2.40 |
Balance Sheet
The company has $11.94 million in cash and $1.17 million in debt, giving a net cash position of $10.77 million or $0.67 per share.
Cash & Cash Equivalents | 11.94M |
Total Debt | 1.17M |
Net Cash | 10.77M |
Net Cash Per Share | $0.67 |
Equity / Book Value | 13.90M |
Book Value Per Share | 0.87 |
Working Capital | 8.19M |
Cash Flow
In the last 12 months, operating cash flow was -$29.89 million and capital expenditures -$250,000, giving a free cash flow of -$30.14 million.
Operating Cash Flow | -29.89M |
Capital Expenditures | -250,000 |
Free Cash Flow | -30.14M |
FCF Per Share | -$1.88 |
Margins
Gross margin is 100.00%, with operating and profit margins of -233,893.33% and -243,040.00%.
Gross Margin | 100.00% |
Operating Margin | -233,893.33% |
Pretax Margin | -243,040.00% |
Profit Margin | -243,040.00% |
EBITDA Margin | -196,240.00% |
EBIT Margin | -224,313.33% |
FCF Margin | -200,913.33% |
Dividends & Yields
TCRT does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -11.60% |
Shareholder Yield | -11.60% |
Earnings Yield | -120.24% |
FCF Yield | -99.40% |
Analyst Forecast
The average price target for TCRT is $45.00, which is 2,319.36% higher than the current price. The consensus rating is "Hold".
Price Target | $45.00 |
Price Target Difference | 2,319.36% |
Analyst Consensus | Hold |
Analyst Count | 3 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | -42.54% |
Stock Splits
The last stock split was on February 1, 2024. It was a reverse split with a ratio of 1:15.
Last Split Date | Feb 1, 2024 |
Split Type | Reverse |
Split Ratio | 1:15 |
Scores
TCRT has an Altman Z-Score of -67.31 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -67.31 |
Piotroski F-Score | 3 |